---
figid: PMC7800773__oncotarget-12-10-g001
figlink: pmc/articles/PMC7800773/figure/F1/
number: F1
caption: The central regulators of the RB1 tumor suppressor are highlighted in the
  gray box. Representative inhibitors of the indicated kinases are depicted in red.
  RABL6A inhibits RB1 by reducing the CDK inhibitor, p27, and activating MEK and Myc.
  Arrows, activating events; perpendicular bars, inhibitory events.
pmcid: PMC7800773
papertitle: Combination therapies for MPNSTs targeting RABL6A-RB1 signaling.
reftext: Jordan L. Kohlmeyer, et al. Oncotarget. 2021 Jan 5;12(1):10-14.
pmc_ranked_result_index: '61001'
pathway_score: 0.9140419
filename: oncotarget-12-10-g001.jpg
figtitle: Combination therapies for MPNSTs targeting RABL6A-RB1 signaling
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7800773__oncotarget-12-10-g001.html
  '@type': Dataset
  description: The central regulators of the RB1 tumor suppressor are highlighted
    in the gray box. Representative inhibitors of the indicated kinases are depicted
    in red. RABL6A inhibits RB1 by reducing the CDK inhibitor, p27, and activating
    MEK and Myc. Arrows, activating events; perpendicular bars, inhibitory events.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - CDK2
  - CDK4
  - CDK6
  - AGFG2
  - RB1
  - MYC
  - Mirdametinib
  - Selumetinib
  - Trametinib
  - Binimetinib
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: HRB1
  symbol: HRBL
  source: hgnc_prev_symbol
  hgnc_symbol: AGFG2
  entrez: '3268'
- word: RB1
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
- word: Мус
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
chemicals:
- word: Mirdametinib
  source: ''
  identifier: ''
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Binimetinib
  source: MESH
  identifier: C581313
diseases: []
figid_alias: PMC7800773__F1
redirect_from: /figures/PMC7800773__F1
figtype: Figure
---
